ArticleFrontiers in oncology2024

Adjuvant sorafenib for hepatocellular carcinoma after radiofrequency ablation versus radiofrequency ablation: analysis of its efficacy and safety.

Wang Junxiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.